Category

• Products2

Organizations

• Bausch + Lomb64
• Alcon, Inc.43
• Eyes On Eyecare43
• American Optometric Association34
• Harrow28
• Glaukos26
• Regeneron22
• Topcon Healthcare22
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• FDA2
• Fda Approval2
• Eye Drop Solution2
• Eye Drops2
• Products2
• IOP1
• Ocular Hypertension1
• Glaucoma1
• Inflammation1
• Ocular Pain1

• Organizations: Amneal Pharmaceuticals✕

Clear all

Products

FDA approves Amneal's bimatoprost 0.01% generic

Generic version of Allergan’s LUMIGAN is indicated for reducing elevated IOP in glaucoma and ocular hypertensive patients.

Products

FDA approves Amneal's prednisolone acetate ophthalmic suspension

Referencing Allergan's Pred Forte, this 1% concentrated drop is expected to hit the U.S. market by Q3 2025.